Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

ZEULIDE DEPOT

VERITY PHARMACEUTICALS INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of ZEULIDE DEPOT in Canada?

A shortage of ZEULIDE DEPOT 22.5MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 30, 2026), but it has not started yet.

When will ZEULIDE DEPOT be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist — only products with a different form or route found
StatusAnticipated Shortage
Same-ingredient products on file2 products · 0 same form & route
Affected strength22.5MG
Report last updated2026-10-30
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

LUPRON DEPOT

ABBVIE CORPORATION

7.5MG · DIN 00836273

Different strengthDifferent dosage formSame routeNo current shortage

ELIGARD

TOLMAR INTERNATIONAL LTD.

30MG · DIN 02248999

Different strengthDifferent dosage formDifferent routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02462699

Strength

22.5MG

Dosage Form

KIT POWDER FOR SUSPENSION (SUSTAINED-RELEASE

Route

INTRAMUSCULAR

Active Ingredient

LEUPROLIDE ACETATE

See all LEUPROLIDE ACETATE products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

Other Products from VERITY PHARMACEUTICALS INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.